23/12/2014 - 19:36
The Food and Drug Administration has approved a topical formulation of ivermectin for the once-daily topical treatment of inflammatory lesions related to rosacea. The drug will be marketed as...
Field of Interest: Dermatology
Categories:
News Feed: Internal Medicine News - Dermatology